Abiomed Inc. (ABMD) - Comprehensive Stock Analysis & Investment Research
Deep dive into Abiomed Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Abiomed Inc., including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Abiomed Inc.: Abiomed Inc. operates in the Manufacturing sector, positioning it as a large-cap market leader.
Abiomed Inc. (Stock Symbol: ABMD) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.
The organization employs approximately 1725 professionals worldwide and operates under the strategic leadership of CEO Michael Minogue.
The company has established itself as a major market leader with significant institutional backing.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Abiomed Inc.'s revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Abiomed Inc.: With $174M in annual revenue and 154.3% net margin, the company demonstrates exceptional profitability.
Annual Revenue: $174 million generating a 154.3% net profit margin .
Market Capitalization: $17211 million - Classified as a large-cap stock with institutional-grade stability.
Return on Equity (ROE): 9.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Abiomed Inc. stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Abiomed Inc.: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Abiomed Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Abiomed Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Abiomed Inc.: Strong free cash flow generation demonstrates solid operational efficiency.
Abiomed Inc. strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .
The company demonstrates robust operational efficiency through strong free cash flow generation of $250 million annually, complemented by impressive -12.8% year-over-year cash flow growth.
The company maintains a healthy 500.8% gross margin, indicating strong pricing power and operational efficiency.